Potential Treatment for Hepatitis-B prevention

In this trial, we are evaluating the safety and pharmacokinetics of an experimental new drug, RBHB1016 being developed to protect people from being infected by the hepatitis B virus.
For this trial we need the help of males and females who are not pregnant or are not able to bear children, aged from 18-45 (inclusive).

If you meet the criteria for this study and would like more information, register below or call 1800 727 874

This requires a 4 night in-house stay with 6 follow up visits.